Hans-Detlev Stahl

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture — primary culture cells markedly differ from fourth-passage cells

Thomas Zimmermann, Elke Kunisch, Robert Pfeiffer et al. · Arthritis Research & Therapy · 2000 · 187 citations · Full text

Medicine, Clinical Sciences, Immunology +13

Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases

Raimund W. Kinne, Thomas Liehr, Volkmar Beensen et al. · Arthritis Research & Therapy · 2001 · 44 citations · Full text

Medicine, Cell Biology, Molecular Genetics +17

A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch

Ivan Berlin, Ian Hunneyball, Doris Greiling et al. · Psychopharmacology · 2012 · 20 citations

Medicine, Pharmacology, Pharmacotherapy +12